Delivery Order SPE2DB20D3304-SPE2DB26FW4K9
Award Date 10/31/25
Potential Completion Date 11/3/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $11,792.85 to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 mL pen injections on June 25, 2025, with an ultimate completion date of June 26, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist medication used for weight management, reflecting the federal government's procurement of...
- The Defense Logistics Agency awarded a delivery order valued at $7,520.28 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This firm fixed-price contract, with an ultimate completion date of August 27, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, and performance will be executed at the...
- The Defense Logistics Agency awarded a $13,150.18 delivery order to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 ml pen injectors on September 9, 2025, with an ultimate completion date of September 10, 2025. This firm fixed-price delivery order, which was competitively awarded with no set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist used for weight management, reflecting the federal...
- The Defense Logistics Agency awarded a delivery order valued at $6,481.97 to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injections. This firm fixed-price delivery order, with an ultimate completion date of May 5, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made on a competitive basis with no set-aside designation. Zepbound is a GLP-1 receptor agonist used for chronic weight management,...
- The Defense Logistics Agency awarded a delivery order valued at $11,314.01 to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections. This firm fixed-price, competitively awarded contract is classified as a non-set-aside procurement and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 30, 2025. Zepbound is a GLP-1 receptor agonist indicated for chronic weight...
- The Defense Logistics Agency awarded a delivery order valued at $23,996.70 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injectors. This firm fixed-price delivery order, which is classified as a child contract with no set-aside designation, has an ultimate completion date of September 11, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist medication...
- The Defense Logistics Agency awarded a delivery order valued at $1,071.60 to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 mL pen injections on September 25, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 26, 2025. Zepbound is a GLP-1 receptor agonist used for weight management and is part of the broader...
- The Defense Logistics Agency awarded a $5,621.91 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections with an ultimate completion date of September 17, 2025. This firm fixed price contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a Delivery Order valued at $10,288.27 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injectors. This competitively awarded contract, utilizing firm fixed pricing with no set-aside designation, calls for delivery by August 8, 2025, to the contractor's facility in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist medication commonly prescribed for weight management and metabolic health support....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Zepbound 12.5 mg/0.5 ml pen injections, valued at $6,035.72. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist...